Cross Talk between the Liver Microbiome and Epigenome in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

The Microbiome possibly plays a role in the epigenome of metabolic dysfunction-associated steatotic liver disease

The development of MASLD (metabolic dysfunction-associated steatotic liver disease), including its severe forms, involves complex biological processes. This study explored the possible connection between the liver microbiome and epigenetic factors.

https://pubmed.ncbi.nlm.nih.gov/38689066/